Drug
Amg 780
Amg 780: highest development phase Phase 1, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMG 780 NCT01137552 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Amg 780 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.